AU Stock MarketDetailed Quotes

NEU Neuren Pharmaceuticals Ltd

Watchlist
  • 12.320
  • -0.340-2.69%
20min DelayMarket Closed Nov 26 16:00 AET
1.60BMarket Cap10.25P/E (Static)

Neuren Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neuren Pharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/H2 -- / 108.600M --
-- 2024/H1 24.327M / 24.100M --
Feb 29, 2024 2023/H2 168.999M / 169.600M --
Aug 28, 2023 2023/H1 64.405M / 63.100M --
-- 2022/H2 16.750M / 13.900M --
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 108.600M--
--2024/H124.327M / 24.100M--
Feb 29, 20242023/H2168.999M / 169.600M--
Aug 28, 20232023/H164.405M / 63.100M--
--2022/H216.750M / 13.900M--

Unlock Free Earnings Estimates

Neuren Pharmaceuticals Ltd Earnings Reports

  • Neuren Pharmaceuticals Ltd: Q3 2024 update

    Nov 7 07:19

  • Neuren Pharmaceuticals Ltd: H1 2024 financial results

    Aug 27 07:17

  • Neuren Pharmaceuticals Ltd: Half Yearly Report and Accounts

    Aug 27 07:12

  • Neuren Pharmaceuticals Ltd: 2023 Annual Report to shareholders

    Apr 23 07:16

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 17, 2024

    Strong Buy

    • Strong Buy

      60.00%

    • Buy

      40.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    AU
    Overall
    Symbol
    Latest Price
    % Chg

    No Data